News
UCSF Commentary: Cervical Cancer Expert Questions Role of HPV Testing in Screening
Screening for cervical cancer has become more complex in the last few years, leaving physicians and patients in a quandary: do they test with the traditional Pap smear or do they add a test for human papilloma virus? Some national guidelines recommend that the combined Pap-plus-HPV "cotest" should
Two UCSF Professors Elected to National Academy of Sciences
An eminent cancer researcher and former director of the UCSF Helen Diller Family Comprehensive Cancer Center, and a leading professor of immunology have been selected as members of the National Academy of Sciences – one of the highest honors that can be accorded an American scientist – in
Acupuncture Helps Pediatric Patients Manage Pain and Nausea
The pink plastic box that Cynthia Kim, MD, EdD, opens at the bedside of a young patient at UCSF Benioff Children’s Hospital San Francisco looks like it might contain art supplies. But inside is everything she needs to provide an ancient form of pain relief. Kim is one of three physicians within the
Overlooked Cells Hold Keys to Brain Organization and Disease, UCSF Study Shows
Scientists studying brain diseases may need to look beyond nerve cells and start paying attention to the star-shaped cells known as "astrocytes," because they play specialized roles in the development and maintenance of nerve circuits and may contribute to a wide range of disorders, according to a
UCSF Health Disparities Leader Honored as 2014 Woman of the Year
Dr. Rena Pasick, Professor of Medicine and Assistant Director, Community Education & Outreach at the UCSF Helen Diller Family Comprehensive Cancer Center, has been selected by the Women Health Care Executives (WHCE) as their 2014 Woman of the Year. Trained in public health, Dr. Pasick's expertise
Pancreatic Cancer "Dream Team" Tackles Baffling, Deadly Disease
UC San Francisco has been selected to join a national "dream team" on pancreatic cancer, part of a project designed to accelerate treatment and discoveries for one of the most deadly forms of cancer. The team was announced on April 7, 2014 during the annual meeting of the American Association for
New Breast Cancer Results Illustrate Promise and Potential of I-SPY 2 Trial
In an innovative clinical trial led by UC San Francisco, the experimental drug neratinib along with standard chemotherapy was found to be a beneficial treatment for some women with newly diagnosed, high-risk breast cancer. Additionally, researchers learned that an algorithm used in the adaptive